Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q6YK33 (INS_GORGO) Gorilla gorilla gorilla (Western lowland gorilla)

Insulin UniProtKBInterProInteractive Modelling

110 aa; Sequence (Fasta) ; 2 identical sequences: Homo sapiens: P01308, I3WAC9

Available Structures

346 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
0.92A structure of 2Zn human insulin at 100K Heteromer
P01308;
25-110
ZN;
Assess
X-ray Structure of Human Recombinant 2Zn insulin at 0.92 Angstrom Heteromer
P01308;
25-110
ZN;ACT;POL;
Assess
Insulin with proline analog HzP at position B28 in the T2 state Heteromer
P01308;
25-110
Assess
T6 Human Insulin at 1.0 A Resolution Heteromer
P01308;
25-110
ZN;
Assess
High resolution structure of the manganese derivative of insulin Heteromer
P01308;
25-110
NA;MN;
Assess
Crystal Structure Analysis of Cu Human Insulin Derivative Heteromer
P01308;
25-110
Assess
1.15A structure of human 2Zn insulin at 293K Heteromer
P01308;
25-110
ZN;
Assess
Insulin with proline analog Pip at position B28 in the T2 state Heteromer
P01308;
25-110
NA;
Assess
Insulin with proline analog FyP at position B28 in the T2 state Heteromer
P01308;
25-110
Assess
Insulin with proline analog DhP at position B28 in the T2 state Heteromer
P01308;
25-110
NA;
Assess
1.2 A structure of T3R3 human insulin at 100 K Heteromer
P01308;
25-110
15×ZN; 12×CL;
Assess
Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… Heteromer
P01308;
25-110
16E;RCO;NA;IMD;ZN;
Assess
Cubic Insulin SAD phasing at 14.2 keV Heteromer
P01308;
25-110
Assess
Insulin with proline analog ThioP at position B28 in the T2 state Heteromer
P01308;
25-110
Assess
X-Ray structure of Insulin Analog GLULISINE Heteromer
P01308;
25-110
ZN;
Assess
Insulin glulisine Heteromer
P01308;
25-110
ZN;FMT;
Assess
Insulin with proline analog HzP at position B28 in the R6 state Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Insulin with proline analog AzeP at position B28 in the T2 state Heteromer
P01308;
25-110
NA;
Assess
The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostat… Heteromer
P01308;
25-110
ZN;
Assess
1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K Heteromer
P01308;
25-110
15×ZN; 12×CL;
Assess
Insulin with proline analog FzP at position B28 in the R6 state Heteromer
P01308;
25-110
IPH;ZN;CL;NA;GOL;ACN;
Assess
Insulin with proline analog HyP at position B28 in the T2 state Heteromer
P01308;
25-110
NA;GOL;
Assess
High resolution x-ray crystal structure of synthetic insulin lispro Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Structure of the T6 human insulin derivative with nickel at 1.35 A resolution Heteromer
P01308;
25-110
NI;NA;
Assess
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and t… Heteromer
P01308;
25-110
ZN;
Assess
Xray crystal structure of isotope-labeled human insulin Heteromer
P01308;
25-110
Assess
Zinc free, dimeric human insulin determined to 1.35 Angstrom resolution Heteromer
P01308;
25-110
EDO;
Assess
Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea Heteromer
P01308;
25-110
NA;RCO;URE;ZN;CL;ARF;
Assess
Monoclinic human insulin in complex with p-coumaric acid Heteromer
P01308;
25-110
ZN;PO4;HC4;SCN;
Assess
Crystal structure of insulin detemir Heteromer
P01308;
25-110
IPH;ZN;CL;MYR;
Assess
INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE Heteromer
P01308;
25-110
ZN;
Assess
Crystal structure of human insulin mutant B20 D-ala, B23 D-ala Heteromer
P01308;
25-110
Assess
Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin … Heteromer
P01308;
25-110
ZN;
Assess
Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II Heteromer
P01308;
25-110
SO4;ACT;
Assess
Crystal structure of desB30 insulin produced by cell free protein synthesis Heteromer
P01308;
25-110
Assess
Crystal structure of human insulin, crystallised in the presence of macrophage migration inhibitory… Heteromer
P01308;
25-110
SO4;GOL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Insulin co-crystallizes in the presence of it beta-cell chaperone sulfatide Heteromer
P01308;
25-110
ZN;CL;NA;
Assess
STRUCTURE OF INSULIN Heteromer
P01308;
25-110
CRS;ZN;CL;
Assess
Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)ami… Heteromer
P01308;
25-110
IMD;KUT;
Assess
High resolution x-ray crystal structure of isotope-labeled ester-insulin Heteromer
P01308;
25-110
Assess
Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form Heteromer
P01308;
25-110
IPH;CL;ZN;GOL;
Assess
Crystal structure of an cyclohexylalanine substituted insulin analog. Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Human insulin analogue (D-ProB8)-insulin Heteromer
P01308;
25-110
CL;
Assess
insuline(60sec) and UV laser excited fluorescence Heteromer
P01308;
25-110
Assess
Structure of human insulin cocrystallized with protamine and urea Heteromer
P01308;
25-110
NA;CRS; 12×URE; 10×ARF;ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human insulin with intra-chain chemical crosslink between modified B27 and B30 Heteromer
P01308;
25-110
10×IPH;ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
A6-A11 trans-dicarba human insulin Heteromer
P01308;
25-110
Assess
Recombinant Human Insulin Heteromer
P01308;
25-110
Assess
Human insulin B26Phe mutant crystal structure Heteromer
P01308;
25-110
SO4;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER Heteromer
P01308;
25-110
ZN;CL;
Assess
High resolution crystal structure of racemic ester insulin Heteromer
P01308;
25-110
PEG;GOL;
Assess
Structure of human insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human insulin Heteromer
P01308;
25-110
Assess
Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-actin… Heteromer
P01308;
25-110
CRS;UZ9;ZN;CL;
Assess
STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Structure of LysB29(Nepsilon omega-carboxyheptadecanoyl) des(B30) Human Insulin Heteromer
P01308;
25-110
RCO;ZN;CL;
Assess
Four-Disulfide Insulin Analog A22/B22 Heteromer
P01308;
25-110
IPH;ACN;ZN;CL;GOL;
Assess
Insulin Lispro Analog Heteromer
P01308;
25-110
CRS;ZN;GOL;CL;
Assess
Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation. Heteromer
P01308;
25-110
SO4;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Insulin single mutant INS-Q Heteromer
P01308;
25-110
SO4;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human insulin with intra-chain chemical crosslink between modified B24 and B29 Heteromer
P01308;
25-110
SO4;
Assess
Structure of human insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I Heteromer
P01308;
25-110
Assess
Crystalization of human zinc insulin at pH 5.5 Heteromer
P01308;
25-110
ZN;CL;
Assess
Structure of human insulin in presence of urea at pH 7.0 Heteromer
P01308;
25-110
RCO;URE;ZN;CL;GOL;
Assess
Crystal Structure of human zinc insulin at pH 5.5 Heteromer
P01308;
25-110
ZN;CL;
Assess
Structure of human insulin in presence of thiocyanate at pH 7.0 Heteromer
P01308;
25-110
RCO;ZN;SCN;GOL;
Assess
Crystal structure of insulin Heteromer
P01308;
25-110
IPH;ZN;CL;MYR;
Assess
Serial Macromolecular Crystallography at ALBA Synchrotron Light Source - Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Crystal Structure of the cobalt human insulin derivative Heteromer
P01308;
25-110
CO;
Assess
Structural and biophysical characterization of a covalent insulin dimer formed during storage of ne… Heteromer
P01308;
25-110
Assess
Crystal structure of aspart insulin at pH 6.5 Heteromer
P01308;
25-110
CRS;ZN;CL;
Assess
Structure of the rhombohedral form of the M-cresol/insulin R6 hexamer Heteromer
P01308;
25-110
CRS;ZN;CL;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Crystal structure of human zinc insulin at pH 6.5 Heteromer
P01308;
25-110
ZN;CL;MG;
Assess
STRUCTURE OF INSULIN Heteromer
P01308;
25-110
IPH;ZN;CL;MYR;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Structure of gadolinium-caged cobalt (III) insulin hexamer Heteromer
P01308;
25-110
CO;GD;CL;
Assess
Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8… Heteromer
P01308;
25-110
ZN;CL;
Assess
Crystal structure of human insulin, crystallised in the presence of macrophage migration inhibitory… Heteromer
P01308;
25-110
SO4;
Assess
Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… Heteromer
P01308;
25-110
ZN;
Assess
Crystal structure form ultalente insulin microcrystals Heteromer
P01308;
25-110
ZN; 12×CL;
Assess
Human insulin B26Asn mutant crystal structure Heteromer
P01308;
25-110
Assess
Human insulin analog: [GluB10,HisA8,ArgA9]-DOI Heteromer
P01308;
25-110
Assess
Human insulin Heteromer
P01308;
25-110
Assess
Crystal structure of human insulin with Ni+2 complex Heteromer
P01308;
25-110
NI;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Crystal structure of aspart insulin at pH 6.5 Heteromer
P01308;
25-110
CRS;ZN;CL;
Assess
Human insulin in complex with serotonin and arginine Heteromer
P01308;
25-110
ZN;CL;ARG;SRO;
Assess
Enhancing the Therapeutic Properties of a Protein by a Designed Zinc-Binding Site, Structural princ… Heteromer
P01308;
25-110
ZN;CL;IPH;
Assess
CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN Heteromer
P01308;
25-110
ZN;
Assess
NMePheB25 insulin analogue crystal structure Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Crystal structure of humnan insulin Sr+2 complex Heteromer
P01308;
25-110
SR;
Assess
The structure of the resorcinol/insulin R6 hexamer Heteromer
P01308;
25-110
RCO;ZN;CL;NA;
Assess
Human insulin with intra-chain chemical crosslink between modified B27 and B29 Heteromer
P01308;
25-110
Assess
Structure of the monoclinic form of the M-cresol/insulin R6 hexamer Heteromer
P01308;
25-110
CRS;ZN;CL;NA;
Assess
THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE Heteromer
P01308;
25-110
ZN;
Assess
THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE Heteromer
P01308;
25-110
ZN;
Assess
Crystal structure of human zinc insulin at pH 6.5 Heteromer
P01308;
25-110
ZN;CL;
Assess
Dehydrated T6 human insulin at 100 K Heteromer
P01308;
25-110
ZN;CL;
Assess
insuline(1sec) and UV laser excited fluorescence Heteromer
P01308;
25-110
Assess
TyrB25,NMePheB26,LysB28,ProB29-insulin analogue crystal structure Heteromer
P01308;
25-110
IPH;CL;ZN;
Assess
Structure of human insulin in presence of thiocyanate at pH 6.5 Heteromer
P01308;
25-110
RCO;ZN;SCN;
Assess
A novel covalently linked insulin dimer Heteromer
P01308;
25-110
Assess
Structure DeltaA1-A4 insulin Heteromer
P01308;
25-110
RCO;ZN;CL;
Assess
Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of pro… Heteromer
P01308;
25-110
ZN;CL;IPH;
Assess
Crystal structure of an unstable insulin analog with native activity. Heteromer
P01308;
25-110
ZN;
Assess
Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state … Heteromer
P01308;
25-110
ZN;CL;
Assess
INSULIN, MONOCLINIC CRYSTAL FORM Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANIS… Heteromer
P01308;
25-110
ZN;
Assess
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL Heteromer
P01308;
25-110
RCO;ZN;CL;
Assess
Structure of Human Arg-Insulin Heteromer
P01308;
25-110
ZN;
Assess
Crystal structure of ni human ARG-insulin Heteromer
P01308;
25-110
12×NI;NA;CL;
Assess
Crystal Structure Analysis of the Human Insulin Heteromer
P01308;
25-110
ZN;CL;GOL;
Assess
Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… Heteromer
P01308;
25-110
IPH;16E;ZN;CL;
Assess
Structure of human insulin in presence of urea at pH 6.5 Heteromer
P01308;
25-110
RCO;URE;ZN;CL;
Assess
T3R3 form of Human insulin with single Zn Heteromer
P01308;
25-110
CRS;NA;ZN;CL;
Assess
Human insulin in complex with cucurbit[7]uril Heteromer
P01308;
25-110
Assess
Insulin with proline analog PiP at position B28 in the R6 state Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Crystal structure of RB human arg-insulin Heteromer
P01308;
25-110
NA;RB;
Assess
Structural properties of the B25Tyr-NMe-B26Phe insulin mutant. Heteromer
P01308;
25-110
IPH;ZN;
Assess
Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 7.5 Heteromer
P01308;
25-110
Assess
Insulin with proline analog HyP at position B28 in the R6 state Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Crystal Structure of Human Insulin complexed with Cu+2 metal ion Heteromer
P01308;
25-110
CU;
Assess
Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of pro… Heteromer
P01308;
25-110
ZN;IPH;CL;
Assess
Monoclinic crystalline form of human insulin, complexed with meta-cresol Heteromer
P01308;
25-110
CRS;EDO;ZN;IS8;
Assess
Human insulin in complex with serotonin Heteromer
P01308;
25-110
ZN;CL;SRO;
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Structure of human insulin cocrystallized with protamine Heteromer
P01308;
25-110
RCO;ZN;CL;
Assess
Insulin with proline analog DfP at position B28 in the R6 state Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Crystal structure of MN human arg-insulin Heteromer
P01308;
25-110
MN;CL;
Assess
Insulin analog containing a YB26W mutation Heteromer
P01308;
25-110
ZN;IPH;CL;
Assess
Dehydrated T6 human insulin at 295 K Heteromer
P01308;
25-110
ZN;
Assess
Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… Heteromer
P01308;
25-110
Assess
Human Insulin Heteromer
P01308;
25-110
ZN;CL;
Assess
Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal… Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
LYS(B28)PRO(B29)-HUMAN INSULIN Heteromer
P01308;
25-110
ZN;
Assess
Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state a… Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies o… Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Crystal Structure of an iodinated insulin analog Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR Heteromer
P01308;
25-110
ZN;CL;
Assess
Crystal structure of aspart insulin at pH 8.5 Heteromer
P01308;
25-110
CRS;ZN;CL;
Assess
Insulin with proline analog DhP at position B28 in the R6 state Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Crystal structure of aspart insulin at pH 8.5 Heteromer
P01308;
25-110
CRS;ZN;CL;
Assess
Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal… Heteromer
P01308;
25-110
ZN;CL;IPH;
Assess
Non-standard Design of Unstable Insulin Analogues with Enhanced Activity Heteromer
P01308;
25-110
ZN;
Assess
HUMAN INSULIN MUTANT SERB9GLU Heteromer
P01308;
25-110
Assess
Crystal structure of aspart insulin at pH 6.5 Heteromer
P01308;
25-110
CRS;ZN;CL;
Assess
Semi-synthetic analogue of human insulin ProB26-DTI Heteromer
P01308;
25-110
IPH;ZN;CL;
Assess
Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SC… Heteromer
P01308; P06213;
25-110
NAG;NAG;NAG;SO4;GOL;NAG;
Assess
crystal structure of human insulin degrading enzyme in complex with iodinated insulin Heteromer
P01308; P14735;
25-110
ZN;DIO;
Assess
Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 Heteromer
P01308; P06213;
25-110
NAG;NAG;NAG;
Assess
Enhancing the activity of insulin by stereospecific unfolding Heteromer
P01308;
25-110
Assess
NMR STRUCTURE OF HUMAN INSULIN under Amyloidogenic Condition, 15 STRUCTURES Heteromer
P01308;
25-110
Assess
Receptor binding redefined by a structural switch in a mutant Human Insulin Heteromer
P01308;
25-110
Assess
MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRU… Heteromer
P01308;
25-110
Assess
HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES Heteromer
P01308;
25-110
Assess
Humal Insulin Mutant B31Lys-B32Arg Heteromer
P01308;
25-110
Assess
allo-ThrA3 DKP-insulin Heteromer
P01308;
25-110
Assess
Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis. Heteromer
P01308;
25-110
Assess
AbaA3-DKP-insulin Heteromer
P01308;
25-110
Assess
FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA Heteromer
P01308;
25-110
ZN;CL;NA;
Assess
human insulin receptor ectodomain bound by 4 insulin Heteromer
P01308; P06213;
25-110
Assess
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 ST… Heteromer
P01308;
25-110
Assess
THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN IN… Heteromer
P01308;
25-110
Assess
NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 struc… Heteromer
P01308;
25-110
Assess
PARADOXICAL STRUCTURE AND FUNCTION IN A MUTANT HUMAN INSULIN ASSOCIATED WITH DIABETES MELLITUS Heteromer
P01308;
25-110
Assess
R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES Heteromer
P01308;
25-110
ZN;IPH;
Assess
Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0 Heteromer
P01308;
25-110
Assess
Solution structure of human insulin at pH 1.9 Heteromer
P01308;
25-110
Assess
Modified A22Gly-B31Arg Human Insulin Heteromer
P01308;
25-110
Assess
HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES Heteromer
P01308;
25-110
Assess
Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-bi… Heteromer
P01308;
25-110
Assess
SOLUTION STRUCTURE OF THE SUPERACTIVE MONOMERIC DES-[PHE(B25)] HUMAN INSULIN MUTANT. ELUCIDATION OF… Heteromer
P01308;
25-110
Assess
NMR structure of human insulin mutant His-B10-Asp, Pro-B28-Lys, Lys-B29-Pro, 20 structures Heteromer
P01308;
25-110
Assess
Biosynthetic engineered A21K-B31K-B32R human insulin monomer structure in water/acetonitrile soluti… Heteromer
P01308;
25-110
Assess
Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue Heteromer
P01308;
25-110
Assess
INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES Heteromer
P01308;
25-110
Assess
NMR structure of human insulin mutant GLY-B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structur… Heteromer
P01308;
25-110
Assess
INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES Heteromer
P01308;
25-110
Assess
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO… Heteromer
P01308;
25-110
Assess
Solution structure of [GlnB22]-insulin mutant at pH 1.9 Heteromer
P01308;
25-110
Assess
NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Str… Heteromer
P01308;
25-110
Assess
NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Str… Heteromer
P01308;
25-110
Assess
NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structur… Heteromer
P01308;
25-110
Assess
INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES Heteromer
P01308;
25-110
Assess
Structure of [D-HisB24] insulin analogue at pH 8.0 Heteromer
P01308;
25-110
Assess
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… Heteromer
P01308;
25-110
Assess
Cryo-EM structure of the IGF1R/insulin complex Heteromer
P01308; P08069;
25-110
NAG;
Assess
NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 struct… Heteromer
P01308;
25-110
Assess
Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9 Heteromer
P01308;
25-110
Assess
B24Y DKP insulin Heteromer
P01308;
25-110
Assess
Biosynthetic engineered A22S-B3K-B31R human insulin monomer structure in water/acetonitrile solutio… Heteromer
P01308;
25-110
Assess
tentative model of the human insulin receptor ectodomain bound by three insulin Heteromer
P01308; P06213;
25-110
Assess
Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists Heteromer
P01308; P06213;
25-110
NAG;NAG;NAG;NAG;NAG;
Assess
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… Heteromer
P01308;
25-110
Assess
Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9 Heteromer
P01308;
25-110
Assess
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE Heteromer
P01308;
25-110
IPH;
Assess
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTATE, AVERAGE STRUCTURE Heteromer
P01308;
25-110
IPH;
Assess
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE Heteromer
P01308;
25-110
IPH;
Assess
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES Heteromer
P01308;
25-110
IPH;
Assess
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES Heteromer
P01308;
25-110
ZN;IPH;
Assess
FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA Heteromer
P01308;
25-110
ZN;CL;NA;
Assess
Solution structure of B24G insulin Heteromer
P01308;
25-110
Assess
NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin Heteromer
P01308;
25-110
Assess
Structure of [L-HisB24] insulin analogue at pH 1.9 Heteromer
P01308;
25-110
Assess
Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solution… Heteromer
P01308;
25-110
Assess
Structure of [D-HisB24] insulin analogue at pH 1.9 Heteromer
P01308;
25-110
Assess
ThrA3-DKP-insulin Heteromer
P01308;
25-110
Assess
Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as r… Heteromer
P01308;
25-110
Assess
Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions. Heteromer
P01308;
25-110
Assess
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… Heteromer
P01308;
25-110
Assess
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTU… Heteromer
P01308;
25-110
Assess
Human Insulin Mutant A22Gly-B31Lys-B32Arg Heteromer
P01308;
25-110
Assess
Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin) Heteromer
P01308;
25-110
Assess
Structure of [L-HisB24] insulin analogue at pH 8.0 Heteromer
P01308;
25-110
Assess
NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES Heteromer
P01308;
25-110
Assess
NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 struc… Heteromer
P01308;
25-110
Assess
NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures Heteromer
P01308;
25-110
Assess
NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) Heteromer
P01308;
25-110
Assess
Enhancing the activity of insulin by stereospecific unfolding Heteromer
P01308;
25-110
Assess
The T2 structure of polycrystalline cubic human insulin Heteromer
P01308;
25-110
Assess
Human insulin analog: [GluB10,TyrB20]-DOI Heteromer
P01308;
25-109
Assess
Human insulin analog: [GluB10,HisA8,ArgA9,TyrB20]-DOI Heteromer
P01308;
25-109
Assess
Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0 Heteromer
P01308;
26-110
NA;
Assess
Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2 Heteromer
P01308;
26-110
ACT;
Assess
Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form Heteromer
P01308;
26-110
ACT;
Assess
Insulin glargine crystal structure 1 Heteromer
P01308;
25-109
Assess
Crystal structure of the B24His-insulin - human analogue Heteromer
P01308;
26-110
SO4;
Assess
X-Ray structure of Insulin Glargine Heteromer
P01308;
25-109
Assess
Insulin glargine crystal structure 2 Heteromer
P01308;
25-109
Assess
Despentapeptide insulin in acetic acid (pH 2) Heteromer
P01308;
26-110
SO4;
Assess
Semi-synthetic analogue of human insulin ProB26-DTI in monomer form Heteromer
P01308;
26-110
Assess
Insulin with proline analog ThioP at position B28 in the R6 state Heteromer
P01308;
26-110
IPH;ZN;CL;
Assess
Human insulin in complex with serotonin and arginine Heteromer
P01308;
26-110
ZN;CL;ARG;SRO;
Assess
Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2 Heteromer
P01308;
26-110
ACT;
Assess
Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2 Heteromer
P01308;
26-110
Assess
Crystal structure of human insulin-degrading enzyme in complex with insulin Heteromer
P01308; P14735;
25-109
ZN;
Assess
Human insulin B26Gly mutant crystal structure Heteromer
P01308;
26-110
SO4;
Assess
Insulin triple mutant INS-RQD Heteromer
P01308;
26-110
Assess
Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 2 In… Heteromer
P01308; P06213;
26-110
Assess
Full-length insulin receptor bound with both site 1 binding deficient mutant insulin (A-V3E) and si… Heteromer
P01308; P15208;
26-110
Assess
Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… Heteromer
P01308; P15208;
26-110
Assess
Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… Heteromer
P01308; P15208;
26-110
Assess
Full-length insulin receptor bound with unsaturated insulin WT (2 insulin bound) symmetric conforma… Heteromer
P01308; P15208;
26-110
Assess
Full-length insulin receptor bound with site 2 binding deficient mutant insulin (B-L17R) -- asymmet… Heteromer
P01308; P15208;
26-110
Assess
Full-length insulin receptor bound with site 2 binding deficient mutant insulin (A-L13R) -- asymmet… Heteromer
P01308; P15208;
26-110
Assess
Structure of Glargine insulin in 20% acetic acid-d4 (pH 1.9) Heteromer
P01308;
25-109
Assess
Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 1 In… Heteromer
P01308; P06213;
26-110
Assess
Full-length insulin receptor bound with site 2 binding deficient mutant insulin (B-L17R) -- symmetr… Heteromer
P01308; P15208;
26-110
Assess
Full-length insulin receptor bound with unsaturated insulin WT (2 insulins bound) asymmetric confor… Heteromer
P01308; P15208;
26-110
Assess
Full-length insulin receptor bound with unsaturated insulin WT (2 insulins bound) asymmetric confor… Heteromer
P01308; P15208;
26-110
Assess
Cryo-EM Structure for the Insulin Binding Region in the Ectodomain of the Full-length Human Insulin… Heteromer
P01308; P06213;
26-110
Assess
Full-length insulin receptor bound with site 2 binding deficient mutant insulin (A-L13R) -- symmetr… Heteromer
P01308; P15208;
26-110
Assess
Full-length insulin receptor bound with unsaturated insulin WT (1 insulin bound) asymmetric conform… Heteromer
P01308; P15208;
26-110
Assess
INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR, 25 STRUCTURES Heteromer
P01308;
26-110
Assess
Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… Heteromer
P01308; P15208;
26-110
Assess
Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)ami… Heteromer
P01308;
27-110
NO3;
Assess
The crystal structure of a human seleno-insulin analog Heteromer
P01308;
27-110
Assess
Crystal structure form ultalente insulin microcrystals Heteromer
P01308;
27-110
12×ZN;MPB;
Assess
Human insulin in complex with the analytical antibody OXI-005 Fab Heteromer
P01308;
27-110
Assess
Leucine-zippered human insulin receptor ectodomain with single bound insulin - "upper" membrane-dis… Heteromer
P01308; P06213;
27-110
NAG;NAG;
Assess
The insulin receptor ectodomain in complex with three venom hybrid insulin molecules - asymmetric c… Heteromer
P01308; P06213;
27-110
Assess
Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin, conf 1 Heteromer
P01308; P06213;
27-110
Assess
The insulin receptor ectodomain in complex with four venom hybrid insulins - symmetric conformation Heteromer
P01308; P06213;
27-110
20×NAG;
Assess
Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin with visible dd… Heteromer
P01308; P06213;
27-110
Assess
Low resolution Cryo-EM structure of the full-length insulin receptor bound to 3 insulin, conf 2 Heteromer
P01308; P06213;
27-110
Assess
Low resolution Cryo-EM structure of the full-length insulin receptor bound to 2 insulin, conf 3 Heteromer
P01308; P06213;
27-110
Assess
Insulin receptor ectodomain dimer complexed with two IRPA-3 partial agonists Heteromer
P01308; P06213;
27-110
Assess
The insulin receptor ectodomain in complex with a venom hybrid insulin analog - "head" region Heteromer
P01308; P06213;
27-110
NAG; 12×NAG;
Assess
Cryo-EM structure of human insulin degrading enzyme in complex with insulin Heteromer
P01308; P14735;
27-110
Assess
Head region of insulin receptor ectodomain (A-isoform) bound to the non-insulin agonist IM462 Heteromer
P01308; P06213;
27-110
NAG;NAG;
Assess
Cryo-EM structure of the full-length human IGF-1R in complex with insulin Heteromer
P01308; P08069;
27-110
NAG;NAG;NAG;
Assess
Insulin Degrading Enzyme pO/pC Heteromer
P01308; P14735;
25-107
Assess
Full-length insulin receptor bound with site 1 binding deficient mutant insulin (A-V3E) Heteromer
P01308; P15208;
28-110
Assess
Insulin Degrading Enzyme pC/pC Heteromer
P01308; P14735;
25-107
Assess
Human insulin in complex with the analytical antibody HUI-018 Fab Heteromer
P01308;
29-110
Assess
Insulin Degrading Enzyme O/pC Heteromer
P01308; P14735;
25-106
Assess
Cryo-EM structure of insulin amyloid-like fibril that is composed of two antiparallel protofilaments Heteromer
P01308;
29-109
Assess
Insulin in complex with Site 1 of the human insulin receptor Heteromer
P01308; P06213;
31-110
NAG;NAG;NAG;
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha… Heteromer
P01308; P06213;
31-110
NAG;NAG;NAG;
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… Heteromer
P01308; P06213;
31-110
NAG;NAG;NAG;
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… Heteromer
P01308; P06213;
31-110
NAG;NAG;NAG;
Assess
Cryo-EM structure of human insulin degrading enzyme in complex with insulin Heteromer
P01308; P14735;
25-98
Assess
crystal structure of human insulin-degrading enzyme in complex with insulin B chain Heteromer
P01308; P14735;
25-49
DIO;
Assess
Insulin Receptor ectodomain in complex with two insulin molecules Heteromer
P01308; P01318; P06213;
90-110
NAG;NAG;NAG;NAG;NAG;
Assess
Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-… Heteromer
P01308; P0DOX5; P14735; Q6GMX0;
90-110
Assess
human insulin receptor bound with A62 DNA aptamer and insulin Heteromer
F8WCM5; P01308; P06213;
90-110
Assess
human insulin receptor bound with A43 DNA aptamer and insulin Heteromer
F8WCM5; P01308; P06213;
90-110
Assess
Insulin Receptor ectodomain in complex with one insulin molecule Heteromer
P01308; P01318; P06213;
90-110
Assess
human insulin receptor bound with A62 DNA aptamer and insulin - locally refined Heteromer
F8WCM5; P01308; P06213;
90-110
Assess
human insulin receptor bound with two insulin molecules Heteromer
F8WCM5; P01308; P06213;
90-110
Assess
Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry Heteromer
P01308; P01318; P06213;
90-110
NAG;NAG;NAG;NAG;NAG;
Assess
Crystal structure of Zn-bound human insulin-degrading enzyme in complex with insulin B chain Heteromer
P01308; P14735;
25-44
ZN;DIO;
Assess
Crystal Structure Analysis of Fab1-Bound Human Insulin Degrading Enzyme (IDE) in Complex with Insul… Heteromer
P01308; P14735;
90-109
ZN;
Assess
Crystal Structure Analysis of Elbow-Engineered-Fab-Bound Human Insulin Degrading Enzyme (IDE) in Co… Heteromer
P01308; P14735;
90-105
EPE;ZN;
Assess
immune complex Heteromer
P01308; P01903; P01911;
77-90
NAG;
Assess
Crystal structure of a human insulin peptide-HLA-DQ8 complex Heteromer
P01308; P01909; P01920;
35-47
NAG;
Assess
immune complex Heteromer
P01308; P01903; P01911;
78-90
NAG;NAG;MLI;
Assess
Human HLA-A*0201-ALWGPDPAAA Heteromer
P01308; P04439; P61769;
15-24
Assess
HLA-A02 carrying AQWGPDPAAA Heteromer
P01308; P04439; P61769;
15-24
Assess
Weak TCR binding to an unstable insulin epitope drives type 1 diabetes Heteromer
P01308; P01902; P61769;
39-48
EDO;GOL;SO4;
Assess
1E6-A*0201-ALWGPDPAAA Complex, Triclinic Heteromer
P01308; P04439; P61769;
15-24
Assess
1E6-A*0201-ALWGPDPAAA Complex, Monoclinic Heteromer
P01308; P04439; P61769;
15-24
SO4;
Assess
1E6 TCR in Complex with HLA-A02 carrying AQWGPDPAAA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01308; P01848; P04439; P61769;
15-24
Assess
Weak TCR binding to an unstable insulin epitope drives type 1 diabetes Heteromer
P01308; P01902; P61769;
39-47
GOL;15P;EDO;SO4;
Assess
Weak TCR binding to an unstable insulin epitope drives type 1 diabetes Heteromer
P01308; P01902; P61769;
39-47
EDO;GOL;SO4;
Assess
Weak TCR binding to an unstable insulin epitope drives type 1 diabetes Heteromer
P01308; P01902; P61769;
39-47
EDO;SO4;
Assess
Human MHC Class I, A24 Allele presenting LWM, Complex with 4C6 TCR Heteromer
A0A5H2UYS3; P01308; P61769;
3-11
SO4;EPE;EDO;
Assess
VEALYL peptide derived from human insulin chain B, residues 12-17homo-8-mer36-41
Assess
Crystal structure of human insulin desB30 precursor with an Alanine-Methionine-Lysine C-peptide in …homo-6-mer25-110
12×ZN;CL;RCO;
Assess
Des-B29,B30-insulinhomo-6-mer25-110
IPH;ZN;CL;
Assess
An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological si…homo-6-mer28-110
Assess
LVEALYL peptide derived from human insulin chain B, residues 11-17homo-4-mer35-41
Assess
Crystal structure of human insulin desB30 precursor with an Alanine-Methionine-Lysine C-peptide in …homo-2-mer25-110
Assess
Crystal structure of human insulin desB30 precursor with an Aspartate-Glycine-Lysine C-peptide in d…homo-2-mer25-110
Assess
Crystal structure of human insulin desB30 precursor with an Alanine-Alanine-Lysine C-peptide in dim…homo-2-mer25-110
Assess
Crystal structure of the monomeric zinc free human insulin A22K, B3E, B26E, B29R, desB30 precursor …monomer25-110
Assess
NMR Structures of Single-chain Insulinmonomer25-110
Assess
Design of an Active Ultra-Stable Single-Chain Insulin Analog 20 Structuresmonomer25-110
Assess
NMR Structure of Proinsulinmonomer25-110
Assess
AN ACTIVE MINI-PROINSULIN, M2PImonomer25-110
Assess
MINI-PROINSULIN, SINGLE CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP AND PEPTID…monomer25-110
Assess
Solution Structure and Dynamics of an Ultra-Stable Single-Chain Insulin Analog STUDIES OF AN ENGINE…monomer25-110
Assess
Solution Structure of a Heat-Resistant Long-Acting Insulin Analogmonomer25-109
Assess
Solution Structure of Human Proinsulin C-Peptidemonomer57-87
Assess
Highly biologically active insulin with additional disulfide bondmonomer90-110
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2lwz.1.Amonomer0.5225-110
91.23
Assess